Notice Number: NOT-HL-09-125
Release Date: April 2, 2009
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov)
On February 23, 2009, the NHLBI issued a Funding Opportunity Announcements (FOA): RFA-HL-10-003 (Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01) http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-10-003.html.
As a result of discussions with potential applicants, a list of Frequently Asked Questions (FAQs) has been developed.
The FAQs for this FOA can be found at: http://www.nhlbi.nih.gov/funding/inits/faq-phase2.htm. This information may be updated periodically without additional notice. NHLBI staff will also respond to questions submitted by potential applicants who contact the program, grants management, and review staff listed in the FOA in the Agency Contacts section.
All other aspects of this FOA remain unchanged.
Inquiries should be directed to:
Andrea L. Harabin, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive
Bethesda, MD 20892-7952
Telephone: (301) 435-0222
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)